WOCKPHARMA2024-10-012024-12-31 WOCKPHARMA2024-10-012024-12-31 WOCKPHARMA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member WOCKPHARMA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses02Member WOCKPHARMA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member WOCKPHARMA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses02Member WOCKPHARMA2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532300 WOCKPHARMA NA Wockhardt Limited Equity 2024-04-01 2025-03-31 2025-02-07 2025-02-03 INR Crores Third quarter 11:45:00 13:25:00 2025-02-07 2025-02-07 Not applicable Single segment Pharmaceuticals 2024-10-01 2024-12-31 Unaudited Standalone 3250000000.00 60000000.00 3310000000.00 640000000.00 460000000.00 -240000000.00 710000000.00 480000000.00 420000000.00 1060000000.00 3530000000.00 -220000000.00 0.00 -220000000.00 0.00 0.00 0.00 0.00 -220000000.00 0.00 0.00 0.00 0.00 -220000000.00 -10000000.00 -230000000.00 0.00 0.00 810000000.00 5 -1.40 -1.40 0.00 0.00 -1.40 -1.40 0.00 0.00 0.00 1. The results were reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on February 07, 2025. The results have been subjected to limited review by the Statutory Auditors of the Company. 2. During the quarter ended December 31, 2024 , the Company has allotted 13,000 ( Year to date: 21,610) Equity shares of face value of Rs. 5/- each pursuant to exercise of employee stock options. 3. Further to the approval of the Board of Directors and Shareholders at their meetings , the Company has, on November 11, 2024, alloted 9,049,773 Equity Shares of Rs. 5/- each to successful Qualified Institutional Buyers at the issue price of Rs.1,105/- per share, aggregating to approximately Rs. 1,000 crore. 4. The Company is exclusively into Pharmaceutical business segment. 5. EPS for the quarter & nine month ended is not annualised. Single segment 2024-04-01 2024-12-31 Unaudited Standalone 10470000000.00 410000000.00 10880000000.00 2340000000.00 1280000000.00 -110000000.00 1980000000.00 1590000000.00 1280000000.00 3040000000.00 11400000000.00 -520000000.00 0.00 -520000000.00 0.00 0.00 0.00 0.00 -520000000.00 0.00 0.00 0.00 0.00 -520000000.00 -10000000.00 -530000000.00 0.00 0.00 810000000.00 5 -3.36 -3.36 0.00 0.00 -3.36 -3.36 0.00 0.00 0.00 Exchange fluctuation loss, net 20000000.00 Other expenses 1040000000.00 Exchange fluctuation loss, net 0.00 Other expenses 3040000000.00 -10000000.00 -10000000.00 0.00 0.00 0.00 0.00